The Absorption, Metabolism and Excretion of [14C]D-0316 in Human

PHASE1UnknownINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 5, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Advanced or Metastatic Non-small Cell Lung
Interventions
DRUG

[14C]D-0316 suspension

Before administration, the drug preparation was placed at room temperature, and 40ml drinking water was added into each bottle to prepare suspension for the subjects to take. 40ml pure water was injected again. After washing the container, the subjects took orally. Repeat the previous step, and then used 160ml purified water. After the administration container was moistened for several times, the subjects took all the moistening lotion. Pay attention not to splash the liquid during mixing outside the bottle

Trial Locations (1)

210029

Jiangsu Province Hospital Affiliated to Nanjing Madical University of Medicine, Nanjing

All Listed Sponsors
lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY